| EQA 2027 - Circulating anticoagulants (ACC) |
|---|
|
Expert Biologists - Program Coordinators:
Béatrice GUILLEMIN EQA performed since 2013
Number of analytical sites registered in 2026: 146 |
| Program organised by ProBioQual and placed under the aegis of the FAEEQ |
|
1 – Program overview
This external quality assessment program evaluates the different methods for detecting circulating anticoagulants. The main commercial reagents are represented.
Statistical reports are sent with supporting comments from the expert clinical biologists / program coordinators.
Participating labs can choose to be assessed for all the analytes of this program, or simply a subset of analytes of interest.
2 – Assessment frequency
Number of surveys per year: 4
Number of control samples per survey: 2
Number of samples per year: 8
3 – List of analytes assessed
Results are evaluated both quantitatively and qualitatively (negative, positive or equivocal).
4 – Description of the control samples
Lyophilised human control plasma (citrate) (samples to be resuspended in 1 mL of distilled water).
warning Sample volume: if necessary, order an additional kit.
| | Legal notices and privacy policy | General Terms of Sale | | Last updated: 17 September 2026 | Copyright © 2011-2026 ProBioQual All rights reserved. |